Advertisement

Testosterone Treatment of Cardiovascular Diseases

Principles and Clinical Experiences

  • Jens Møller
  • H. Einfeldt

Table of contents

  1. Front Matter
    Pages I-IX
  2. Jens Møller, H. Einfeldt
    Pages 1-3
  3. Jens Møller, H. Einfeldt
    Pages 4-5
  4. Jens Møller, H. Einfeldt
    Pages 6-6
  5. Jens Møller, H. Einfeldt
    Pages 7-9
  6. Jens Møller, H. Einfeldt
    Pages 10-13
  7. Jens Møller, H. Einfeldt
    Pages 14-27
  8. Jens Møller, H. Einfeldt
    Pages 28-32
  9. Jens Møller, H. Einfeldt
    Pages 33-41
  10. Jens Møller, H. Einfeldt
    Pages 42-46
  11. Jens Møller, H. Einfeldt
    Pages 47-48
  12. Jens Møller, H. Einfeldt
    Pages 49-50
  13. Jens Møller, H. Einfeldt
    Pages 51-52
  14. Jens Møller, H. Einfeldt
    Pages 53-53
  15. Jens Møller, H. Einfeldt
    Pages 54-55
  16. Back Matter
    Pages 56-84

About this book

Introduction

For many years now I have devoted much of my time to lecturing and writing on the subject of cardiovascular disease (CVD). In this book I have outlined the development of my approach to this problem. I must admit that the details of my theories have undergone continuous modification as a result of the lessons learned in treating a large number of patients, but the basic message has remained the same. I believe that the delay in the utilization oftestosterone treatment for CVD has arisen from a failure by specialists in endocrinology, biochemistry, physi­ ology, and cardiology to understand each other's point of view and therefore to effectively coordinate their clinical efforts. This is like four people starting to climb the various faces of a pyramid, unaware of each other's presence until they reach the apex. It is hoped that bringing specialists in these different disciplines together at "summit meetings" will help them discover the true nature of this disease, the cardiovascular specialist understanding the underlying lack of anabolic steroids, and the other three grasping the way in which treatment with these compounds can effectively counteract the metabolic disturbance which is the cause of CVD. Even apart of the language barrier, writing this book has by no means been an easy task. Please consider my situation; one cannot be a cardiologist, endocrinologist, biologist, biochemist, and physiologist all in one person. This fact may open me to criticism.

Keywords

cardiology cardiovascular endocrinology heart disease steroid steroids vascular disease

Authors and affiliations

  • Jens Møller
    • 1
  • H. Einfeldt
    • 2
  1. 1.European Organization for the Control of Circulatory Diseases (EOCCD)Store Kongensgade 36Copenhagen KDenmark
  2. 2.Krankenhaus St. GeorgHamburg 1Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-61744-7
  • Copyright Information Springer-Verlag Berlin Heidelberg 1984
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-61746-1
  • Online ISBN 978-3-642-61744-7
  • Buy this book on publisher's site